Clinical evaluation of bioactive composite resin in class V lesions in high-risk caries patients: A randomized split-mouth trial

生物活性复合树脂在龋齿高危患者V类龋损中的临床评价:一项随机分口试验

阅读:1

Abstract

BACKGROUND: Recurrent caries at tooth-restoration interfaces remains a primary reason for restoration replacement. The challenge is developing biomaterials that prevent demineralization or promote remineralization. The study aimed to clinically evaluate and compare bioactive composite resin (CR), Predicta Bioactive Bulk, and nonbioactive CR in class V lesions of high-risk caries patients using the FDI criteria. SUBJECTS AND METHODS: Twenty high caries risk adult patients with bilaterally symmetrical posterior buccal caries were selected. Restorations with either Predicta Bioactive composite or nonbioactive composite were undertaken and recalled for clinical evaluation at baseline (1 month), 3, 6, and 12 months using the FDI criteria. The data were analyzed using the SPSS software (Windows Version 22.0, Released 2013). Mean, standard deviation, frequency, proportions, Chi-square test, Cochran's Q test, and McNemar's post hoc test were assessed at P < 0.05 significance. RESULTS: There were no statistically significant differences in the clinical performance of bioactive and nonbioactive composites in terms of marginal staining, fracture and retention, marginal adaptation, and recurrence of initial pathology. CONCLUSION: Predicta Bioactive Bulk and 3M™ Filtek™ Bulk Fill Posterior Restorative demonstrated equivalent effectiveness in the restoration of class V caries in high-risk caries patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。